130445-13-5Relevant academic research and scientific papers
Direct one-pot synthesis of naphthoxindoles from 4-bromooxindoles by Suzuki-Miyaura coupling and aldol condensation reactions
Park, Kyeong-Yong,Kim, Bum Tae,Heo, Jung-Nyoung
, p. 164 - 170 (2014/01/06)
An efficient one-pot synthesis of naphthoxindoles by using 4-bromoindolin-2-ones and 2-formylphenylboronic acids has been developed. The coupling reaction proceeds in good to excellent yields under microwave irradiation through a Suzuki-Miyaura coupling a
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors
Chen, Meng-Hsin,Fitzgerald, Patricia,Singh, Suresh B.,O'Neill, Edward A.,Schwartz, Cheryl D.,Thompson, Chris M.,O'Keefe, Stephen J.,Zaller, Dennis M.,Doherty, James B.
, p. 2222 - 2226 (2008/09/20)
Synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
-
, (2008/06/13)
Compounds described by the chemical formula (I) or a pharmaceutically acceptable salt thereof: are inhibitors of p38 useful in the treatment of inflammatory diseases such as arthritis.
p38 inhibitors: Piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones
Hunt, Julianne A.,Kallashi, Florida,Ruzek, Rowena D.,Sinclair, Peter J.,Ita, Ida,McCormick, Sherrie X.,Pivnichny, James V.,Hop, Cornelis E. C. A.,Kumar, Sanjeev,Wang, Zhen,O'Keefe, Stephen J.,O'Neill, Edward A.,Porter, Gene,Thompson, James E.,Woods, Andrea,Zaller, Dennis M.,Doherty, James B.
, p. 467 - 470 (2007/10/03)
We have synthesized a series of C7-piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones that are highly potent inhibitors of both p38 MAP kinase activity and TNF-α release. The 4-aminopentamethylpiperidin
Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase
Stelmach, John E.,Liu, Luping,Patel, Sangita B.,Pivnichny, James V.,Scapin, Giovanna,Singh, Suresh,Hop, Cornelis E. C. A.,Wang, Zhen,Strauss, John R.,Cameron, Patricia M.,Nichols, Elizabeth A.,O'Keefe, Stephen J.,O'Neill, Edward A.,Schmatz, Dennis M.,Schwartz, Cheryl D.,Thompson, Chris M.,Zaller, Dennis M.,Doherty, James B.
, p. 277 - 280 (2007/10/03)
The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors of p38α MAP kinase is described. These analogues are hybrids of a pyridinylimidazole p38α inhibitor reported by Merck Research Laboratories and VX-745. O
Synthesis of 3H2-Tyr1>Leucine-enkephalin
Hasegawa, Hiroshi,Akagawa, Nobuyoshi,Shinohara, Yoshihiko,Baba, Shigeo
, p. 2085 - 2088 (2007/10/02)
The synthesis of 3H2-Tyr1>leucine-enkephalin by the catalytic tritiation of 1>leucine-enkephalin is described.The precursor amino acid, 2,6-dibromo-DL-tyrosine, was synthesized in three step
